The 2518 A/G polymorphism in the MCP-1 gene and cancer risk: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 6, 2013, Pages 3575-3579

  Jia, Liu Qun ^a   Shen, Yong Chun ^a   Guo, Shu Jin ^a   Hu, Qian Jing ^a   Pang, Cai Shuang ^a   Wang, Tao ^a   Chen, Lei ^a   Wen, Fu Qiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cancer; Ethnicity; MCP 1; Meta analysis; Polymorphism

Indexed keywords

EID: 84882719802     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.6.3575     Document Type: Article

References (22)

1. Attar R, Agachan B, Kuran SB, et al (2010). Association of CCL2 and CCR2 gene variants with endometrial cancer in Turkish women. In Vivo, 24, 243-8.
2. Balkwill F, Mantovani A (2001). Inflammation and cancer: back to Virchow?. Lancet, 357, 539-45.
3. Bektas-Kayhan K, Unur M, Boy-Metin Z, Cakmakoglu B (2012). MCP-1 and CCR2 gene variants in oral squamous cell carcinoma. Oral Dis, 18, 55-9.
4. Chen MK, Yeh KT, Chiou HL, et al (2011). CCR2-64I gene polymorphism increase susceptibility to oral cancer. Oral Oncol, 47, 577-82.
5. Gu H, Ni M, Guo X, et al (2011). The functional polymorphism in monocyte chemoattractant protein-1 gene increases susceptibility to gastric cancer. Med Oncol, 28, S280-5.
6. Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.
7. Kruszyna L, Lianeri M, Rubis B, et al (2011). CCL2 -2518 A/G single nucleotide polymorphism as a risk factor for breast cancer. Mol Biol Rep, 38, 1263-7.
8. Kucukgergin C, Isman FK, Cakmakoglu B, Sanli O, Seckin S (2012a). Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer. DNA Cell Biol, 31, 1418- 24.
9. Kucukgergin C, Isman FK, Dasdemir S, et al (2012b). The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer. Gene, 511, 7-11.
10. Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancerrelated inflammation. Nature, 454, 436-44.
11. Narter KF, Agachan B, Sozen S, Cincin ZB, Isbir T (2010). CCR2-64I is a risk factor for development of bladder cancer. Genet Mol Res, 9, 685-92.
12. O'Hayre M, Salanga CL, Handel TM, Allen SJ (2008). Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J, 409, 635-49.
13. Rollins BJ, Walz A, Baggiolini M (1991). Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood, 78, 1112-6.
14. Rovin BH, Lu L, Saxena R (1999). A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun, 259, 344-8.
15. Saenz-Lopez P, Carretero R, Cozar JM, et al (2008). Genetic polymorphisms of RANTES, IL1-A, MCP-1 and TNF-A genes in patients with prostate cancer. BMC Cancer, 8, 382.
16. Shi CL, Yu CH, Zhang Y, et al (2011). Monocyte chemoattractant protein-1 modulates invasion and apoptosis of PC-3M prostate cancer cells via regulating expression of VEGF, MMP9 and caspase-3. Asian Pac J Cancer Prev, 12, 555-9.
17. Singh V, Srivastava P, Srivastava N, et al (2012). Association of inflammatory chemokine gene CCL2I/D with bladder cancer risk in North Indian population. Mol Biol Rep, 39, 9827-34.
18. Vazquez-Lavista LG, Lima G, Gabilondo F, Llorente L (2009). Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder. Urology, 74, 414-8.
19. Wu HH, Lee TH, Tee YT, et al (2013). Relationships of Single Nucleotide Polymorphisms of Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 With Susceptibility and Clinicopathologic Characteristics of Neoplasia of Uterine Cervix in Taiwan Women. Reprod Sci.
20. Yang L, Shi GL, Song CX, Xu SF (2010). Relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China. Genet Mol Res, 9, 765-71.
21. Yeh CB, Tsai HT, Chen YC, et al (2010). Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma. J Surg Oncol, 102, 264-70.
22. Yoshie O, Imai T, Nomiyama H (2001). Chemokines in immunity. Adv Immunol, 78, 57-110.